November 1, 2024 | COVID, Patient Retention, clinical trials, influenza, patient recruitment
The Northern Hemisphere flu season is fast approaching, bringing with it a multitude of challenges for respiratory clinical trials. The exact dates of the flu season in the Northern Hemisphere vary every year, but it is usually from October to May, with peaks of activity between December and May.

Is your study prepared to recruit and retain patients effectively? In our, “Key Considerations for Patient Recruitment and Retention – Part #1,” we explore essential strategies to ensure your trial stands out.
🔍 Highlights:
⭐️Patient Awareness: Learn how to increase trial visibility and engage the local community.
⭐️Community Outreach: Discover effective methods to reach potential participants.
⭐️Referral Networks: Optimize your network to maximize patient recruitment.
Read the full blog now and get ahead this flu season!👉 https://bit.ly/3WVnVEm
This content was provided by Innovative Trials
Company Details
Latest Content from Innovative Trials
See how Innovative Trials supported a Top 5 pharma to complete enrollment in a Phase 2 Lupus study
Innnovative Trials’ Equality & Diversity committee celebrates Pride Month
Discover how community engagement could enhance diversity in clinical trials patient recruitment
Innovative Trials, a global clinical trial patient recruitment and retention company based in Hertfordshire, has been recognised for its contribution to the county’s economy and business reputation.
For clinical trial participants, navigating their way through a study can sometimes seem daunting and complicated. Without the right support, around 30% are likely to drop out [1], resulting in…
Kate Shaw, Founder & CEO, comments on the Lord report of the Lord O’Shaughnessy review into commercial clinical trials in the UK.
Eloise Moffett joins Innovative Trials as New Vice President of Commercial to drive business growth globally
The news comes after a report by the Association of the British Pharmaceutical Industry (ABPI) highlighted a 44% decline in industry clinical trials in the UK over the last five…
Global clinical trials are a vital component of pharma R&D. Utilizing sites in multiple countries not only provides increased access to eligible and diverse patients – and therefore more robust…
Kate Shaw, Innovative Trials’ Founder & CEM, reflects on the exciting news for patients affected by cancer in the UK.
